Evidence
- discover-1_2022_rct_meaningful-improvement-in-general-health-outcomes-with-guselkumab-treatment-for-psoriatic-arthritis-patient-reported-outcomes-measurement-information-system-29-results-from-a-phase-3-study
- discover-1_2022_rct_meaningful-improvement-in-general-health-outcomes-with-guselkumab-treatment-for-psoriatic-arthritis-patient-reported-outcomes-measurement-information-system-29-results-from-a-phase-3-study
- discover-1_2022_rct_meaningful-improvement-in-general-health-outcomes-with-guselkumab-treatment-for-psoriatic-arthritis-patient-reported-outcomes-measurement-information-system-29-results-from-a-phase-3-study
- maheu_2025_rct_pilot-randomized-controlled-trial-of-icanwork-theory-guided-return-to-work-intervention-for-individuals-touched-by-cancer
- orbai_2022_rct_meaningful-improvement-in-general-health-outcomes-with-guselkumab-treatment-for-psoriatic-arthritis
- orbai_2022_rct_meaningful-improvement-in-general-health-outcomes-with-guselkumab-treatment-for-psoriatic-arthritis